The UK has a lot to offer to domestic and international visitors, with busy cities, beautiful countryside, and historical monuments dating back to the Stone Age. The pandemic has had a significant effect on the UK tourism. It is still in the early stages of recovery from an international viewpoint. However, demand for domestic tourism has skyrocketed, and many lodging providers have planned for the summer of 2022.

The Republic of Ireland is home to some of the world’s most recognized historical sites. However, due to the pandemic, Ireland’s tourist visits have decreased at a rate comparable to those of the UK.

The UK and Ireland destination tourism insight report provides an analysis of destination markets, infrastructure and attractions, main and emerging source markets, as well as risks and opportunities in the UK and Ireland. The report also explores the types of travelers that visit the region and provides a SWOT analysis.

The invasion of Ukraine by Russia has highlighted the need for NATO and Europe to strengthen and consolidate their forces. Historically, Slovenia’s defense budget has been extremely limited in size, with little spent on the acquisition of new technologies. As such, Slovenia has been left vulnerable to the aggressions of its adversaries. As a country that is heavily reliant on collective defense to maintain its security, Slovenia’s defense expenditure is largely driven by its ongoing commitment to international organizations.

What are the military doctrines and defense strategies in Slovenia? Slovenia is in the process of restructuring part of its forces to meet new operational requirements. One of the greatest changes will be the creation of various battalions. Slovenia’s military strategy revolves around its participation in, and commitment to, international organizations such as NATO and the EU. Slovenia will lean on these groups as it modernizes its forces, looking to bilateral and multilateral agreements with allies to procure new equipment and transfer knowledge and skills. This knowledge transfer will also occur through participation in various exercises led by other member states. Moreover, Slovenia is trying to equip itself with the most modern forces available.

Wet (Neovascular / Exudative) Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Wet (Neovascular / Exudative) Macular Degeneration pipeline landscape. The report provides comprehensive information on the therapeutics under development for Wet (Neovascular / Exudative) Macular Degeneration, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: * This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase. * Certain sections in the report may be removed or altered based on the availability and relevance of data. * Global Markets Direct, is a research brand owned and operated by GlobalData.

Vulvovaginal Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Vulvovaginal Candidiasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Vulvovaginal Candidiasis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Vascular Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Vascular Injury pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Vascular Injury, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The cumulative capacity for thermal power in the UK power market was 42.5 GW in 2021. The market is expected to grow at a CAGR of less than 1% from 2021 to 2035. The UK thermal power market report offers comprehensive information and understanding of the thermal power market in the UK. The report gives information on the different types of power sources available in the country. The key companies in the UK thermal power market are SSE Plc, National Grid Plc, E.ON UK Plc, BP Plc, and Royal Dutch Shell Plc.

SSE Plc: The company generates, transmits, distributes, and supplies electricity, and produces, stores, distributes, and supplies gas. It has interests in electricity transmission businesses in the north of Scotland, electricity distribution in the north of Scotland and southern central England, and gas distribution in Scotland and southern England. SSE also offers gas storage and energy portfolio management services.

Tyrosyl DNA Phosphodiesterase 1 (TDP1 or EC 3.1.4.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Tyrosyl DNA Phosphodiesterase 1 (TDP1 or EC 3.1.4.) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Additionally, the report analyses the pipeline products across relevant therapy areas under development and provides an overview of key players involved in Tyrosyl DNA Phosphodiesterase 1 (TDP1 or EC 3.1.4.) targeted therapeutics development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Trauma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Trauma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The Tanzania renewable industry report offers comprehensive information on major policies governing the renewable energy market in the country. The report discusses renewable energy targets and plans along with the present policy framework, giving a fair idea of overall growth potential of the renewable energy industry. The report also provides major technology specific policies and incentives provided in the country. The Energy and Water Utilities Regulatory Authority (EWURA) is the body overseeing the electricity sector in Tanzania. Its objectives include protecting stakeholder interests and ensuring that service providers’ financial viability is sustained. The EWURA has the authority to issue licenses, review and determine rates and charges, approve power purchase agreements (PPA), ensure supply security and energy efficiency and promote competitiveness in the energy market.

Systemic Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Systemic Candidiasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Systemic Candidiasis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Stent retrievers are deployed by a catheter that is threaded through the clot. Once the stent is fully deployed, the stent is retrieved with the clot attached. GlobalData's Medical Devices sector report, “Stent Retrievers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Stent Retrievers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Stent Retrievers report provides key information and data related to:

Extensive coverage of the Stent Retrievers under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates

The South Africa over-the-counter (OTC) healthcare market size was valued at $633.4 million in the year 2021. The market is expected to grow at a CAGR of more than 3% during the forecast period. The South Africa OTC healthcare market report provides insights on high growth markets to target, trends in the usage of category level distribution data and companies market shares. The key categories in the OTC healthcare market in South Africa include analgesics, cough and cold preparations, first aid kits, indigestion preparations, medicated skin products, plasters & bandages, topical OTC medicines, traditional medicines, vitamins and minerals, and other OTC healthcare products. Traditional medicines was the largest category in 2021, and is also forecast to register the fastest value growth during 2021–2026.

Skin Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Skin Ulcers pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Skin Ulcers, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Salmonella Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Salmonella Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Salmonella Infections, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Rhinitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rhinitis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: * This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase. * Certain sections in the report may be removed or altered based on the availability and relevance of data. * Global Markets Direct, is a research brand owned and operated by GlobalData.

Pulmonary Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Pulmonary Radiation Toxicity pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pulmonary Radiation Toxicity , complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The number of plaque psoriasis clinical trials conducted globally, has increased for the period 2017-2021. The global plaque psoriasis (psoriasis vulgaris) clinical trials review report H2 2021 provides an overview of the plaque psoriasis clinical trials scenario. This report provides top-line data relating to the clinical trials on plaque psoriasis. In total, more than 1,700 clinical trials were conducted on plaque psoriasis, as of February 2022. Among these trials, over 700 clinical trials were conducted in North America.

Plaque psoriasis clinical trials market in Asia-Pacific

In the Asia-Pacific region, China has the highest number of plaque psoriasis clinical trials followed by Australia, Japan, India, and South Korea.

Plaque psoriasis clinical trials market in Europe

Among the European countries, Germany has the highest number of plaque psoriasis clinical trials, followed by the UK, France, Poland, and Spain.

Plaque psoriasis clinical trials market in North America

In the country-wise analysis, the US has the highest number of plaque psoriasis clinical trials in North America followed by Canada and Mexico.